Professional Summary

Professional Overview

Sally Hampton is a seasoned biopharmaceutical executive with over 20 years of industry experience. As the Vice President of Research at KalVista Pharmaceuticals Ltd, she oversees the company's research and early development pipeline, driving innovation and guiding strategic decision-making to advance novel therapeutic candidates.

Experience Summary

Current Role

As Vice President of Research at KalVista Pharmaceuticals Ltd since 2016, Sally is responsible for leading the company's research efforts, managing a team of scientists, and directing the progression of early-stage drug candidates through preclinical development. Under her leadership, KalVista has expanded its pipeline and secured multiple industry partnerships, demonstrating her ability to drive scientific progress and deliver tangible results.

Career Progression

Prior to her current role, Sally held positions of increasing responsibility at KalVista Pharmaceuticals and Vantia Ltd, serving as Director of Program Management, Head of Biology, and Group Head of Lead Discovery. She previously worked as a Senior Scientist and Principal Scientist at GlaxoSmithKline, where she contributed to the advancement of several drug candidates.

Academic Background

Sally holds a Ph.D. in Molecular Biology from the University of Cambridge, where her research focused on novel target identification and validation. Her strong academic background, combined with her extensive industry experience, has equipped her with a deep understanding of the biopharmaceutical landscape and a proven track record of successful drug development.

Areas of Expertise

• Expertise in target identification, lead optimization, and preclinical drug development

• In-depth knowledge of the drug discovery process, from target selection to candidate nomination

• Proven ability to build and lead high-performing research teams

• Successful track record of securing industry partnerships and external funding

• Excellent project management and strategic planning skills

Professional Impact

Under Sally's leadership, KalVista Pharmaceuticals has expanded its research pipeline, with several novel drug candidates progressing through early-stage development. She has played a crucial role in fostering collaborative partnerships, securing over $100 million in funding, and guiding the company's research efforts to address unmet medical needs in the areas of ophthalmology and rare diseases.

Conclusion

With her extensive industry experience, strong scientific background, and demonstrated leadership skills, Sally Hampton is a valuable asset to KalVista Pharmaceuticals. Her commitment to driving innovation and delivering tangible results positions her as a respected and influential figure in the biopharmaceutical industry.